These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17990852)

  • 1. Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles.
    Laaksonen T; Santos H; Vihola H; Salonen J; Riikonen J; Heikkilä T; Peltonen L; Kumar N; Murzin DY; Lehto VP; Hirvonen J
    Chem Res Toxicol; 2007 Dec; 20(12):1913-8. PubMed ID: 17990852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size.
    Santos HA; Riikonen J; Salonen J; Mäkilä E; Heikkilä T; Laaksonen T; Peltonen L; Lehto VP; Hirvonen J
    Acta Biomater; 2010 Jul; 6(7):2721-31. PubMed ID: 20036766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.
    Korhonen E; Rönkkö S; Hillebrand S; Riikonen J; Xu W; Järvinen K; Lehto VP; Kauppinen A
    Eur J Pharm Biopharm; 2016 Mar; 100():1-8. PubMed ID: 26686646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles.
    Vale N; Mäkilä E; Salonen J; Gomes P; Hirvonen J; Santos HA
    Eur J Pharm Biopharm; 2012 Jun; 81(2):314-23. PubMed ID: 22418076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The noncellular reduction of MTT tetrazolium salt by TiO₂ nanoparticles and its implications for cytotoxicity assays.
    Lupu AR; Popescu T
    Toxicol In Vitro; 2013 Aug; 27(5):1445-50. PubMed ID: 23531555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications.
    Mori M; Almeida PV; Cola M; Anselmi G; Mäkilä E; Correia A; Salonen J; Hirvonen J; Caramella C; Santos HA
    Eur J Pharm Biopharm; 2014 Nov; 88(3):635-42. PubMed ID: 25305585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
    Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) cells.
    Ahmad S; Ahmad A; Schneider KB; White CW
    Int J Toxicol; 2006; 25(1):17-23. PubMed ID: 16510353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.
    Huotari A; Xu W; Mönkäre J; Kovalainen M; Herzig KH; Lehto VP; Järvinen K
    Int J Pharm; 2013 Sep; 454(1):67-73. PubMed ID: 23834832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular interactions of surface modified nanoporous silicon particles.
    Bimbo LM; Sarparanta M; Mäkilä E; Laaksonen T; Laaksonen P; Salonen J; Linder MB; Hirvonen J; Airaksinen AJ; Santos HA
    Nanoscale; 2012 May; 4(10):3184-92. PubMed ID: 22508528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductase-like activity of silicon nanowire arrays.
    Wang H; Jiang W; Yuan L; Wang L; Chen H
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1800-5. PubMed ID: 23388083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction assay for evaluating the viability of Escherichia coli cells.
    Wang H; Cheng H; Wang F; Wei D; Wang X
    J Microbiol Methods; 2010 Sep; 82(3):330-3. PubMed ID: 20619304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
    Shrestha N; Shahbazi MA; Araújo F; Zhang H; Mäkilä EM; Kauppila J; Sarmento B; Salonen JJ; Hirvonen JT; Santos HA
    Biomaterials; 2014 Aug; 35(25):7172-9. PubMed ID: 24844163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles.
    Bimbo LM; Mäkilä E; Raula J; Laaksonen T; Laaksonen P; Strommer K; Kauppinen EI; Salonen J; Linder MB; Hirvonen J; Santos HA
    Biomaterials; 2011 Dec; 32(34):9089-99. PubMed ID: 21864895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of MTT by flavonoids in the absence of cells.
    Peng L; Wang B; Ren P
    Colloids Surf B Biointerfaces; 2005 Oct; 45(2):108-11. PubMed ID: 16150580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells.
    Heikkilä T; Santos HA; Kumar N; Murzin DY; Salonen J; Laaksonen T; Peltonen L; Hirvonen J; Lehto VP
    Eur J Pharm Biopharm; 2010 Mar; 74(3):483-94. PubMed ID: 20025968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Surface Chemistry on Ibuprofen Adsorption and Confinement in Mesoporous Silicon Microparticles.
    Mäkilä E; Kivelä H; Shrestha N; Correia A; Kaasalainen M; Kukk E; Hirvonen J; Santos HA; Salonen J
    Langmuir; 2016 Dec; 32(49):13020-13029. PubMed ID: 27951684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.
    Shearman MS; Hawtin SR; Tailor VJ
    J Neurochem; 1995 Jul; 65(1):218-27. PubMed ID: 7790863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular toxicity of nanogenomedicine in MCF-7 cell line: MTT assay.
    Ahmadian S; Barar J; Saei AA; Fakhree MA; Omidi Y
    J Vis Exp; 2009 Apr; (26):. PubMed ID: 19352311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.